10 PRIMECAP Management 10x Genomics Trades
PRIMECAP Management acquired 30 Thousand 10x Genomics shares worth $263 Thousand. That's 0.00% of their equity portfolio (316th largest holding). The first 10x Genomics trade was made in Q1 2020. Since then PRIMECAP Management bought shares five more times and sold shares on four occasions. The investor's estimated purchase price is $893 Thousand, resulting in a loss of 71%.
News about 10x Genomics Inc - Ordinary Shares - Class A and PRIMECAP Management
Why Is NanoString (NSTG) Stock Up 115% Today?
Life science applications specialist NanoString (NASDAQ: NSTG ), which provides tools for discovery and translation research, announced that it has entered i...
ExodusPoint Capital Management LP buys $1.43 million worth of 10x Genomics, Inc. (NASDAQ:TXG) shares
ExodusPoint Capital Management LP Buys 39,250 Shares of 10x Genomics, Inc. (NASDAQ:TXG) Valued at $1,430,000 On June 11, 2023, it was reported that ExodusPoi...
Next generation sequencing (NGS) Market | Investment by Pharmaceutical and Biotechnology Companies Fuel the Industry Growth
Pune, April 05, 2022 (GLOBE NEWSWIRE) -- The market for next generation sequencing can be segmented based on product & services, technology, application, end...
Charles Schwab Investment Management Inc. Has $107.91 Million Stock Holdings in 10x Genomics, Inc. (NASDAQ:TXG)
Charles Schwab Investment Management Inc. grew its position in 10x Genomics, Inc. (NASDAQ:TXG) by 4.3% during the 2nd quarter, according to its most recent 1...